share_log

180 Life Sciences | 3: Initial statement of beneficial ownership of securities-Director Smith Ryan Lewis

180 Life Sciences | 3: Initial statement of beneficial ownership of securities-Director Smith Ryan Lewis

180 Life Sciences | 3:首次持股声明-董事 Smith Ryan Lewis
美股SEC公告 ·  03/11 21:24

Moomoo AI 已提取核心信息

Ryan Lewis Smith, a director and 10% owner of 180 Life Sciences Corp, has filed an initial statement of beneficial ownership with the SEC, as per Form 3 requirements. The filing, dated March 7, 2024, indicates that Smith does not beneficially own any non-derivative or derivative securities of the company. The form, signed on March 11, 2024, is a standard disclosure for insiders of public companies, detailing their holdings and transactions in the company's stock. This filing is part of the regulatory compliance under Section 16(a) of the Securities Exchange Act of 1934.
Ryan Lewis Smith, a director and 10% owner of 180 Life Sciences Corp, has filed an initial statement of beneficial ownership with the SEC, as per Form 3 requirements. The filing, dated March 7, 2024, indicates that Smith does not beneficially own any non-derivative or derivative securities of the company. The form, signed on March 11, 2024, is a standard disclosure for insiders of public companies, detailing their holdings and transactions in the company's stock. This filing is part of the regulatory compliance under Section 16(a) of the Securities Exchange Act of 1934.
180生命科学公司的董事兼10%所有者瑞安·刘易斯·史密斯已根据表格3的要求向美国证券交易委员会提交了初步的实益所有权声明。该文件日期为2024年3月7日,表明史密斯不以实益方式拥有该公司的任何非衍生或衍生证券。该表格于2024年3月11日签署,是上市公司内部人士的标准披露内容,详细说明了他们在公司股票中的持股和交易。该文件是1934年《证券交易法》第16(a)条规定的监管合规的一部分。
180生命科学公司的董事兼10%所有者瑞安·刘易斯·史密斯已根据表格3的要求向美国证券交易委员会提交了初步的实益所有权声明。该文件日期为2024年3月7日,表明史密斯不以实益方式拥有该公司的任何非衍生或衍生证券。该表格于2024年3月11日签署,是上市公司内部人士的标准披露内容,详细说明了他们在公司股票中的持股和交易。该文件是1934年《证券交易法》第16(a)条规定的监管合规的一部分。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息